Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

DRMAW

Dermata Therapeutics, Inc.

CIK 0001853816 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.01
↓ 0.00 (-1.60%)
as of Jul 10, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$50.28K
P/E Ratio
-0.01
EPS
-8.16
Dividend Yield
Not covered
52W Position
12%
Beta
-1.10

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.01
P/S
Not covered
EV/Revenue
Not covered
ROE
-110.8%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 12%
$0.01$0.03

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$7.56M
Total Assets
$7.86M
Free Cash Flow
–

Recent news